Home Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders
Article
Licensed
Unlicensed Requires Authentication

Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders

  • Sven Jarius , Diego Franciotta , Roberto Bergamaschi , Brigitte Wildemann and Klaus-Peter Wandinger
Published/Copyright: February 26, 2010

Abstract

Background: Neuromyelitis optica (NMO, Devic syndrome) is an inflammatory disorder of the central nervous system of putative autoimmune etiology that primarily affects the optic nerves and spinal cord. NMO is frequently associated with immunoglobulin G (IgG) antibodies to aquaporin-4 (AQP4-IgG), which are thought to be involved in the patho-genesis of the disease. The frequency and diagnostic relevance of immunoglobulin M (IgM) antibodies to aquaporin-4 (AQP4-IgM) in patients with NMO is essentially not known. Testing for AQP4-IgM may be of importance since 20%–30% of patients with NMO are negative for AQP4-IgG. Moreover, IgM antibodies are more potent activators of complement compared with IgG, and are detectable at NMO lesional sites.

Methods: Serum samples from 42 patients with NMO spectrum disorders (NMOSD) and from 66 controls were tested for IgM AQP4-Ab using a cell-based assay employing HEK293 cells transfected with human full length AQP4. To control for possible interactions between IgG and IgM, serum was depleted of IgG prior to testing by indirect immunofluorescence.

Results: IgM AQP4-Ab were detectable in 4/42 samples from patients with NMOSD, but in none of the 66 control samples. In three patients, titers were higher following depletion of total IgG from the samples. One sample was positive only after precipitation of total IgG.

Conclusions: AQP4 antibodies of the IgM class exist in almost 10% of patients with NMO and might contribute to lesion pathology. Routine testing for AQP4-IgM appears to not be justified, as all AQP4-IgM positive patients were also positive for AQP4-IgG, and none of the AQP4-IgG negative samples were positive for AQP4-IgM.

Clin Chem Lab Med 2010;48:659–63.


Corresponding author: Prof. Dr. Brigitte Wildemann, Deputy Head of Department of Neurology, Head of Division of Molecular Neuroimmunology, University of Heidelberg, Heidelberg, Germany Phone: +49-6221-56-7504, Fax: +49-6221-56-5461,

Received: 2009-10-16
Accepted: 2010-1-5
Published Online: 2010-02-26
Published in Print: 2010-05-01

©2010 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorials
  2. Laboratory medicine and natural disasters: are we ready for the challenge?
  3. Reference values: still a critical issue in laboratory medicine
  4. Review
  5. Contemporary platelet function testing
  6. Minireviews
  7. Disasters: where they find us
  8. Inter-laboratory variation in cerebrospinal fluid biomarkers for Alzheimer's disease: united we stand, divided we fall
  9. Opinion Paper
  10. Glycated hemoglobin (HbA1c): old dogmas, a new perspective?
  11. Guidelines and Recommendations
  12. IFCC reference procedures for measurement of the catalytic concentrations of enzymes: corrigendum, notes and useful advice
  13. Recommendations for the implementation of international standardization of glycated hemoglobin in Italy
  14. Genetics and Molecular Diagnostics
  15. UGT2B17 and SULT1A1 gene copy number variation (CNV) detection by LabChip microfluidic technology
  16. Genetic polymorphisms of CYP1A2, CYP3A4, CYP3A5, pregnane/steroid X receptor and constitutive androstane receptor in 207 healthy Spanish volunteers
  17. Automated genomic DNA extraction from saliva using the QIAxtractor
  18. General Clinical Chemistry and Laboratory Medicine
  19. A new statistical method for evaluating long-term analytical performance of laboratories applied to an external quality assessment scheme for flow cytometry
  20. Evaluation of the Becton-Dickinson rapid serum tube: does it provide a suitable alternative to lithium heparin plasma tubes?
  21. Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders
  22. Evaluation of the new body fluid mode on the Sysmex XE-5000 for counting leukocytes and erythrocytes in cerebrospinal fluid and other body fluids
  23. Extracellular haemoglobin, oxidative stress and quality of red blood cells relative to perioperative blood salvage
  24. Positive predictive value of serological diagnostic measures in celiac disease
  25. Retinol potentiates the inhibitory effect of ascorbic acid on uric acid assay
  26. Reference Values and Biological Variations
  27. Reference intervals for brain natriuretic peptide in healthy newborns and infants measured with an automated immunoassay platform
  28. Factors influencing serum total tryptase concentrations in a general adult population
  29. Leptin and adiponectin levels in pubertal children: relationship with anthropometric variables and body composition
  30. Cardiovascular risk factors and γ-glutamyltransferase fractions in healthy individuals
  31. Cancer Diagnostics
  32. Combined analysis of survivin autoantibody and carcinoembryonic antigen biomarkers for improved detection of colorectal cancer
  33. Oligoclonal bands and immunoglobulin isotype switch during monitoring of patients with multiple myeloma and autologous hematopoietic cell transplantation: a 16-year experience
  34. Letters to the Editor
  35. Methodological weakness in using correlation coefficients for assessing the interchangeability of analyte data between samples collected under different sampling conditions – the example of matrix metalloproteinase 9 determined in serum and plasma samples
  36. Intralipid causes falsely increased glucose concentrations with the Hemocue glucose analyzer
  37. Serum cholesterol: required and actual bias values
  38. Abstracts
  39. ISMD2010 Eighth International Symposium on Molecular Diagnostics
Downloaded on 18.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2010.127/html
Scroll to top button